2023

1. Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study

   DIAGNOSTIC AND PROGNOSTIC RESEARCH, Vol. 7, Núm. 1